PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance

• 主要な著者: K. O. Shnaider (著者), M. L. Maximov (著者), V. A. Baranova (著者), A. A. Nekipelova (著者)
• フォーマット: 図書
• 出版事項: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2023-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Scientific relevance. The main cause of cardiovascular pathologies is atherosclerosis, which is secondary to lipid metabolism disorders, in particular, the accumulation of low-density lipoprotein (LDL) cholesterol. Dyslipidaemia treatment with the largest evidence base predominantly includes statins...